Pulmonary Embolism Evaluation in the Emergency Department
Summary
Pulmonary embolism evaluation relies on structured pretest probability, D-dimer where appropriate, and imaging. The standard of care addresses whether the physician's risk assessment and testing decisions were reasonable.
Key points
- Pretest probability tools guide who needs testing and which test.
- D-dimer is useful in lower-risk patients but has limits.
- Imaging decisions balance diagnostic yield against risk.
- PE can present with subtle or nonspecific symptoms.
Structured risk assessment
Pulmonary embolism is a classic example of a condition that requires structured thinking. Rather than testing every patient or none, emergency physicians use validated pretest probability assessment to decide who needs a D-dimer, who needs imaging, and who can be safely evaluated without either. The reasonableness of that risk assessment is the heart of most disputes.
A credible review considers the documented history, risk factors, and vital signs, and asks whether the chosen pathway was appropriate for the patient's risk category.
The limits of testing
D-dimer is sensitive but not specific, and its usefulness depends on applying it to the right population. Imaging carries its own considerations. The standard of care does not require that every patient be imaged, and a defensible analysis avoids the hindsight assumption that testing should always have been pursued.
Frequently asked questions
Should every patient with chest pain or shortness of breath be tested for PE?
No. Structured risk assessment determines who warrants testing. Testing every patient would expose many to unnecessary risk, and the standard of care reflects a reasonable, risk-based approach.